Pediatrics
Conference Coverage
Who’s at risk for depression on isotretinoin?
Large Scottish study concludes prior depressive history is the sole predictor.
Photo Challenge
Sparse Hair on the Scalp
A 5-year-old girl presented to our clinic with sparse scalp hair. Her mother reported thinning of the hair and breakage that appeared shortly...
Latest News
Poor and minority children with food allergies overlooked and in danger
“If you are diagnosed with a food allergy and you don’t have disposable income or disposable time, there is really no way that you will be able to...
Clinical Review
Pediatric Procedural Dermatology
Pediatric patients often present with unique diagnoses, and procedures in this population often require special tools. This article provides a...
Clinical Review
Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis in Pediatric Patients
In November 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released their recommendations regarding...
Case Reports
Palmoplantar Eruption in a Patient With Mercury Poisoning
Mercury exposure should be included in the differential diagnosis in patients presenting with a rash of the palms and soles, especially in young...
Original Research
The Gips Procedure for Pilonidal Disease: A Retrospective Review of Adolescent Patients
The Gips procedure is an easy-to-use outpatient procedure for adolescents with pilonidal disease.
Conference Coverage
‘Soak-and-smear’ AD protocol backed by evidence
Frequent bathing with moisturizer is now part of a validated strategy for control of atopic dermatitis in children.
News
COVID-19: U.S. sets new weekly high in children
“Heightened wave of infections” brings nearly 200,000 more child cases in October.
Conference Coverage
Birch bark derivative gel found effective for EB, in phase 3 study
"This is the first large clinical trial with placebo of a topical treatment that's worked for this terrible disease."
Conference Coverage
No lab monitoring needed in adolescents on dupilumab
Reassuring safety results from LIBERTY AD PED-OLE, an open-label extension study.